However, the role of this receptor in endometrial cancer is still controversial, as some studies reported downregulation of ERβ in endometrial cancer [7–9], and others observed increased expression of this receptor in endometrial tumor tissue or its association with disease progression [10–12]. This evidence concerns the gene ESR2 and endometrial cancer.